Stanford Coronary Risk Intervention Project (SCRIP)

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT00000508
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
114

Study Details

Study Description

Brief Summary

To determine whether modification of risk factors altered the rate of progression of coronary artery disease in arteries with mild atherosclerosis and no mechanical intervention in patients who had coronary bypass surgery or percutaneous transluminal coronary angioplasty (PTCA).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: smoking cessation
  • Behavioral: diet, reducing
  • Behavioral: exercise
  • Behavioral: diet, fat-restricted
Phase 3

Detailed Description

BACKGROUND:

Because of difficulties with quantitative measurement and with feasibility of follow-up, few controlled studies prior to SCRIP had been completed to determine the impact of risk factor modification directly on the progression of coronary atherosclerosis in humans. Suggestive evidence existed from animal studies, especially in primates, that diet and exercise altered atherosclerosis as a result of risk modification. But these animal models did not accurately represent the potential for modifying the coronary atherosclerotic process in humans. Some indirect evidence had been developed in humans by studying arteries more accessible than the coronaries. In the several preliminary studies reported using coronary arteriography to study the impact of risk modification on atherosclerosis, the results had been encouraging but far from definitive. One angiographic follow-up study of vein bypass grafts and severely atherosclerotic coronary arteries reported improvement with lipid lowering therapy. None of these studies had included randomization of patients to systematic, intense, long-term risk reduction versus usual care with prospectively identified coronary artery segments with mild disease.

DESIGN NARRATIVE:

Randomized, fixed-sample. A total of 300 patients were randomized, 155 to usual care (UC) in the community and 145 to special intervention (SI). The SI group received intensive efforts directed at reducing or eliminating risk factors, including lowering LDL-cholesterol and increasing HDL-cholesterol, reducing blood pressure, eliminating cigarette smoking and obesity, increasing exercise, and decreasing stressful life experience. The major endpoint was the rate of coronary artery disease progression as measured by angiography, at baseline and at forty-eight months. Follow-up was for four years.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Primary Purpose:
Prevention
Study Start Date :
Sep 1, 1983
Study Completion Date :
Mar 1, 1993

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Men and women, up to 75 years of age. Patients with coronary artery disease but no mechanical intervention on all major vessels.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Stanford University
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • : Edwin Alderman, Stanford University
    • : Ronald Krauss, University of California

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00000508
    Other Study ID Numbers:
    • 27
    • R01HL028292
    First Posted:
    Oct 28, 1999
    Last Update Posted:
    Jan 12, 2016
    Last Verified:
    Mar 1, 1993

    Study Results

    No Results Posted as of Jan 12, 2016